Radiotherapy for Early Mediastinal Hodgkin Lymphoma According to the German Hodgkin Study Group (GHSG): the Roles of Intensity-Modulated Radiotherapy and Involved-Node Radiotherapy

Citation:
Koeck, J., Y. Abo-Madyan, F. Lohr, F. Stieler, an Kriz, R. - P. Mueller, F. Wenz, and H. T. Eich, "Radiotherapy for Early Mediastinal Hodgkin Lymphoma According to the German Hodgkin Study Group (GHSG): the Roles of Intensity-Modulated Radiotherapy and Involved-Node Radiotherapy", Int. J. of Radiation Oncology, 2011.

Abstract:

Purpose: Cure rates of early Hodgkin lymphoma (HL) are high, and avoidance of late complications and second malignancies have become increasingly important. This comparative treatment planning study analyzes to what extent target volume reduction to involved-node (IN) and intensity-modulated (IM) radiotherapy (RT), compared with involved-field (IF) and three-dimensional (3D) RT, can reduce doses to organs at risk (OAR).

Notes:

n/a

Tourism